Nature's Miracle Holding Settles Lawsuit With Megaphoton

Reuters02-09 19:01
Nature's Miracle Holding Settles Lawsuit With Megaphoton

Nature's Miracle Holding Inc. has resolved litigation with Megaphoton, Inc., which had accused Nature's Miracle and its subsidiaries of breaching a contract and guarantee agreement. Both parties have agreed to dismiss all claims against each other with prejudice following a settlement reached on February 2, 2026. As part of the settlement, Nature's Miracle will pay Megaphoton $300,000 by June 30, 2026, appoint an executive from Megaphoton to its board of directors and as president of its agriculture operations, and use its best efforts to uplist its common stock on the New York Stock Exchange or Nasdaq within 180 days. If the uplisting is not approved, the executive will receive 15 million shares of unrestricted common stock. The agreement also includes mutual releases of all claims and customary terms, with no admission of wrongdoing by either party.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nature's Miracle Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013365), on February 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment